The Federal Trade Commission has given the green light to Amgen's purchase of Horizon Therapeutics.

Share:
More In Business
Cava: Q2 Earnings Snapshot
Cava Group Inc. (CAVA) on Tuesday reported second-quarter profit of $6.5 million, beating Wall Street's expectations.
Load More